5,096 results on '"*INTERLEUKIN-2"'
Search Results
102. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.
- Author
-
Hall, William A., Karrison, Theodore G., Rosenthal, Seth A., Amin, Mahul B., Gomella, Leonard G., Purdy, James A., Sartor, A. Oliver, Michalski, Jeff M., Garzotto, Mark G., Bergom, Carmen, Jani, Ashesh B., Lawton, Colleen A.F., Simko, Jeffry P., Moore, Joan K., Gore, Elizabeth M., Lee, W. Robert, Nguyen, Paul L., Danielson, Brita L., Sandler, Howard M., and Feng, Felix Y.
- Subjects
- *
TUMOR necrosis factors , *GRANULOCYTE-macrophage colony-stimulating factor , *IMMUNE response , *RADIOTHERAPY , *PROGRESSION-free survival , *INTERLEUKINS , *INTERLEUKIN-2 , *INTERFERONS , *RESEARCH funding , *PROSTATE tumors - Abstract
Purpose: The immunoinflammatory state has been shown to be associated with poor outcomes after radiation therapy (RT). We conducted an a priori designed validation study using serum specimens from Radiation Therapy Oncology Group (RTOG) 0521. It was hypothesized the pretreatment inflammatory state would correlate with clinical outcomes.Methods and Materials: Patients on RTOG 0521 had serum banked for biomarker validation. This study was designed to validate previous findings showing an association between elevations in C-reactive protein (CRP) and shorter biochemical disease free survival (bDFS). CRP levels were measured in pretreatment samples. An exploratory panel of related cytokines was also measured including: monocyte chemotactic protein-1, granulocyte-macrophage colony-stimulating factor, interferon-γ, interleukin (IL)-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-17A, IL-23, and tumor necrosis factor. The primary endpoint examined was bDFS. Additional exploratory endpoints included overall survival, distant metastases, and toxicity events attributed to RT.Results: Two hundred and two patients in RTOG/NRG 0521 had serum samples available. Median age was 66 years (48-83), and 90% of patients were White. There was not an association between CRP and bDFS (adjusted hazard ratio [HR], 1.07 per 1 log increase in CRP; 95% confidence interval, 0.83-1.38; P = .60). In the exploratory, unplanned analysis, pretreatment IL-10 was significantly associated with worse bDFS (adjusted HR, 1.61 per log increase; P = .0027) and distant metastases (HR, 1.55 per log increase; P = .028). The association of IL-10 with bDFS was maintained on a multiplicity adjustment. The exploratory analyses of pretreatment levels of interferon-γ, IL-1b, IL-2, IL-13, IL-23 were negatively associated with grade 2 or higher pollakiuria (adjusted odds ratio, 0.64, 0.65, 0.71, 0.72, and 0.74, respectively, all P < .05), and IL-6 was negatively associated with grade 2 or higher erectile dysfunction (odds ratio, 0.62; P = .027).Conclusions: Pretreatment CRP was not associated with a poorer bDFS after RT. In a hypothesis- generating analysis, higher baseline levels of IL-10 were associated with lower rates of bDFS. These findings require additional prospective evaluation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
103. Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02.
- Author
-
Siefker-Radtke, Arlene O., Cho, Daniel C., Diab, Adi, Sznol, Mario, Bilen, Mehmet A., Balar, Arjun V., Grignani, Giovanni, Puente, Erika, Tang, Lily, Chien, David, Hoch, Ute, Choudhury, Arkopal, Yu, Danni, Currie, Sue L., Tagliaferri, Mary A., Zalevsky, Jonathan, Hurwitz, Michael E., and Tannir, Nizar M.
- Subjects
- *
TRANSITIONAL cell carcinoma , *NIVOLUMAB , *CANCER patients , *GENE expression profiling , *TUMOR-infiltrating immune cells - Abstract
Bempegaldesleukin plus nivolumab was well tolerated and showed antitumor activity in this preliminary investigation of first-line treatment in patients with locally advanced or metastatic urothelial carcinoma in a phase 2 cohort from the open-label, multicohort phase 1/2 PIVOT-02 study. Despite recent changes in the treatment landscape, there remains an unmet need for effective, tolerable, chemotherapy-free treatments for patients with advanced/metastatic urothelial carcinoma (mUC), especially cisplatin-ineligible patients. To evaluate the immunostimulatory interleukin-2 cytokine prodrug bempegaldesleukin (BEMPEG) plus nivolumab in patients with advanced/mUC from the phase 2 multicenter PIVOT-02 study. This open-label, multicohort phase 1/2 study enrolled patients with previously untreated locally advanced/surgically unresectable or mUC (N = 41). Patients received BEMPEG 0.006 mg/kg plus nivolumab 360 mg intravenously every 3 wk. The primary objectives were safety and the objective response rate (ORR) in patients with measurable disease at baseline and at least one postbaseline tumor response assessment (response-evaluable). Secondary objectives were overall survival (OS) and progression-free survival (PFS). Exploratory biomarker analyses via univariate logistic regression were performed to test the association between potential biomarkers (CD8+ tumor-infiltrating lymphocytes, tumor mutational burden, and IFN-γ gene expression profile) and response. The ORR was 35% (13/37 evaluable patients) and the complete response rate was 19% (7/37 patients); the median duration of response was not reached. Median PFS was 4.1 mo (95% confidence interval [CI] 2.1–8.7) and median OS was 23.7 mo (95% CI 15.8–not reached). Overall, 40/41 patients (98%) experienced at least one treatment-related adverse event (TRAE); grade 3/4 TRAEs occurred in 11 patients (27%), most commonly pyrexia (4.9%; 2 patients). Exploratory biomarker analyses showed no association between biomarkers and response. Limitations include the small sample size and single-arm design. BEMPEG plus nivolumab was well tolerated and showed antitumor activity as first-line treatment in patients with locally advanced/mUC. We investigated an immune-stimulating prodrug called bempegaldesleukin plus the antibody nivolumab as the first therapy for patients with advanced or metastatic cancer of the urinary tract. This combination had manageable treatment-related side effects and was effective in a subset of patients. This trial is registered at ClinicalTrials.gov as NCT02983045. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
104. The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients.
- Author
-
Liu, Hongyun, Liu, Xiaoyan, Zhang, Guoyang, Wang, Jieyu, Naren, Duolan, Xie, Shuangfeng, Li, Yiqing, Nie, Danian, Li, Zhixiong, and Ma, Liping
- Subjects
- *
IDIOPATHIC thrombocytopenic purpura , *REGULATORY T cells , *TH2 cells , *T helper cells , *RECEIVER operating characteristic curves , *BLOOD platelet disorders - Abstract
Dexamethasone (DXM) or immunoglobulin (IVIg) are first-line therapies for primary immune thrombocytopenia (ITP), with an effective rate of 80 %. Some patients with both severe bleeding symptoms and platelet counts of <30 × 109/L received a combination of DXM and IVIg. Autoimmune disorders, especially involving CD4+ T-cells, play a key role in the pathogenesis of ITP. We assumed that variations in the immune status of CD4+ T-cells will lead to different treatment responses. Until now, there have been few relevant clinical studies on CD4+ T-cells and the outcome of first-line therapies. A prospective study enrolling 42 newly diagnosed ITP patients and 30 normal control volunteers was performed. The profiles of major CD4+ T-cells, including T helper (Th)1, Th2, Th17, and regulatory T (Treg) cells, and the related levels of interleukin (IL)-2, IL-17, and IL-23 were examined. The platelet number was recorded at the time point of day 0, day 14, and day 30. Greater concentrations of Th1 and Th17 cells and lower relative numbers of Treg cells were found in the ITP group. As for the treatment outcome on day 14, the profiles of Th2 and IL-2 were significantly greater in the NR group, while the expression of IL-17 was elevated in the CR group. As for the treatment outcome on day 30, higher levels of Th2 cells were observed in those patients who needed 2× pulses of HD DXM compared to those who needed only 1× pulse of HD DXM and IVIg, and receiver operating characteristic curve analysis showed that lower Treg cell may predict favorable values. Meanwhile, the higher IL-23 value may predict a poor early response. Our results indicate that Th1, Th17, and Treg cells and IL-2 and IL-23 participate in the onset of ITP. Higher profiles of Th2, IL-2 and IL-23 may predict poor treatment outcomes. Higher levels of IL-17 and lower profile of Treg may predict sensitivity to HD DXM and IVIg combination therapy. • T helper (Th)1, and regulatory T (Treg)-cells and interleukin (IL)-2 and IL-23 participate in the onset of ITP. • Higher profiles of Th2, IL-2 and IL-23 may predict poor outcomes with dexamethasone and immunoglobulin combined treatment. • Higher levels of IL-17 and lower profile of Treg cells may predict the sensitivity response to first line combined therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
105. The present and future of immunocytokines for cancer treatment.
- Author
-
Gout, Dennis Y., Groen, Lotte S., and van Egmond, Marjolein
- Subjects
- *
CHIMERIC proteins , *IMMUNOSUPPRESSION , *CANCER treatment , *KILLER cells , *IMMUNOGLOBULIN G , *RITUXIMAB - Abstract
Monoclonal antibody (mAb) therapy has successfully been introduced as treatment of several lymphomas and leukemias. However, solid tumors reduce the efficacy of mAb therapy because of an immune-suppressive tumor micro-environment (TME), which hampers activation of effector immune cells. Pro-inflammatory cytokine therapy may counteract immune suppression in the TME and increase mAb efficacy, but untargeted pro-inflammatory cytokine therapy is limited by severe off-target toxicity and a short half-life of cytokines. Antibody-cytokine fusion proteins, also referred to as immunocytokines, provide a solution to either issue, as the antibody both acts as local delivery platform and increases half-life. The antibody can furthermore bridge local cytotoxic immune cells, like macrophages and natural killer cells with tumor cells, which can be eliminated after effector cells are activated via the cytokine. Currently, a variety of different antibody formats as well as a handful of cytokine payloads are used to generate immunocytokines. However, many potential formats and payloads are still left unexplored. In this review, we describe current antibody formats and cytokine moieties that are used for the development of immunocytokines, and highlight several immunocytokines in (pre-)clinical studies. Furthermore, potential future routes of development are proposed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
106. Two Distinct Mechanisms Underlying γδ T Cell-Mediated Regulation of Collagen Type I in Lung Fibroblasts.
- Author
-
Okuno, Daisuke, Sakamoto, Noriho, Akiyama, Yoshiko, Tokito, Takatomo, Hara, Atsuko, Kido, Takashi, Ishimoto, Hiroshi, Ishimatsu, Yuji, Tagod, Mohammed S. O., Okamura, Haruki, Tanaka, Yoshimasa, and Mukae, Hiroshi
- Subjects
- *
FIBROBLASTS , *IDIOPATHIC pulmonary fibrosis , *COLLAGEN , *T cells , *LUNGS , *INTERLEUKIN-2 - Abstract
Idiopathic pulmonary fibrosis is a chronic intractable lung disease, leading to respiratory failure and death. Although anti-fibrotic agents delay disease progression, they are not considered curative treatments, and alternative modalities have attracted attention. We examined the effect of human γδ T cells on collagen type I in lung fibroblasts. Collagen type I was markedly reduced in a γδ T cell number-dependent manner following treatment with γδ T cells expanded with tetrakis-pivaloxymethyl 2-(thiazole-2-ylamino) ethylidene-1,1-bisphosphonate (PTA) and interleukin-2. Collagen type I levels remained unchanged on addition of γδ T cells to the culture system through a trans-well culture membrane, suggesting that cell–cell contact is essential for reducing its levels in lung fibroblasts. Re-stimulating γδ T cells with (E)-4-hydroxy-3-methylbut-2-enyl diphosphate (HMBPP) reduced collagen type I levels without cell–cell contact, indicating the existence of HMBPP-induced soluble anti-fibrotic factors in γδ T cells. Adding anti-interferon-γ (IFN-γ)-neutralizing mAb restored collagen type I levels, demonstrating that human γδ T cell-derived IFN-γ reduces collagen type I levels. Conversely, interleukin-18 augmented γδ T cell-induced suppression of collagen type I. Therefore, human γδ T cells reduce collagen levels in lung fibroblasts via two distinct mechanisms; adoptive γδ T cell transfer is potentially a new therapeutic candidate. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
107. The Interrelation between Interleukin-2 and Schizophrenia.
- Author
-
Huang, Yu, Zhang, Xin, and Zhou, Na
- Subjects
- *
INTERLEUKIN-2 , *SCHIZOPHRENIA , *POISONS , *IMMUNE response , *PEOPLE with schizophrenia - Abstract
Interleukin-2 (IL-2) is a growth factor that regulates T-cell autocrine secretion and has long been considered to be closely related to immune response. With the advance in neuroinflammation theory and immunology research on schizophrenia, it is interesting and meaningful to discuss the possible role of IL-2 in schizophrenia. Here, we reviewed a series of studies published from the 1990s and found that IL-2 was closely associated with schizophrenia. For example, IL-2 is responsible for mediating toxic reactions, which are the causes of schizophrenia symptoms in patients, and such symptoms resolve after discontinuation of the drug. In addition, we focused on the changes of IL-2 in the onset, progression and treatment of schizophrenia and the possible mechanisms by which IL-2 affects schizophrenia. Our review suggests that IL-2 is associated with schizophrenia and plays a role in its pathogenesis, and progression IL-2 and sIL-2R could serve as potential biomarkers of schizophrenia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
108. Treatment Options in Refractory Autoimmune Encephalitis.
- Author
-
Dinoto, Alessandro, Ferrari, Sergio, and Mariotto, Sara
- Subjects
- *
ENCEPHALITIS , *INTRAVENOUS immunoglobulins , *BLOOD-brain barrier , *DRUG efficacy , *DARATUMUMAB , *STEROID drugs , *THERAPEUTIC use of proteins , *AUTOIMMUNE thyroiditis , *INTERLEUKIN-2 , *METHOTREXATE , *CYCLOPHOSPHAMIDE - Abstract
Autoimmune encephalitis represents a potentially treatable immune-mediated condition that is being more frequently recognized. Prompt immunotherapy is a key factor for the management of autoimmune encephalitis. First-line treatments include intravenous steroids, plasma exchange, and intravenous immunoglobulins, which can be combined in most severe cases. Rituximab and cyclophosphamide are administered as second-line agents in unresponsive cases. A minority of patients may still remain refractory, thus representing a major clinical challenge. In these cases, treatment strategies are controversial, and no guidelines exist. Treatments proposed for refractory autoimmune encephalitis include (1) cytokine-based drugs (such as tocilizumab, interleukin-2/basiliximab, anakinra, and tofacitinib); (2) plasma cell-depleting agents (such as bortezomib and daratumumab); and (3) treatments targeting intrathecal immune cells or their trafficking through the blood-brain barrier (such as intrathecal methotrexate and natalizumab). The efficacy evidence of these drugs is mostly based on case reports or small case series, with few reported controlled studies or systematic reviews. The aim of the present review is to summarize the current evidence and related methodological issues in the use of these drugs for the treatment of refractory autoimmune encephalitis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
109. Influence of biologically active substances on synthesis function and cellular destruction of hepatocytes in vitro.
- Author
-
Shkuropat, A. V., Shvets, V. A., Golovchenko, I. V., and Prosiannikova, Ya. M.
- Subjects
- *
CELL physiology , *LIVER cells , *ORGAN culture , *ASPARTATE aminotransferase , *ALANINE aminotransferase - Abstract
The aim of the study was to reveal the effect of biologically active substances on the synthesis activity and cellular destruction of hepatocytes in vitro. Liver sections were prepared for investigation and placed in culture vials with DMEM nutrient medium with 15% calf serum, glucose, and antibiotics (streptomycin and penicillin). Liver sections were incubated for 14 days with interleukin-2 (roncoleukin) at a concentration of 5000 IU/ml and 7500 IU/ml, and erythropoietin (epobiocrine, "Biopharma", USA) at a concentration of 13 IU/ml (high concentration), 6.5 IU/ml (medium concentration) and 1.3 IU/ml (low concentration) and without stimulation (control cultures). Synthesis activity and cellular destruction of hepatocytes were studied by determining the protein content, alanine aminotransferase and aspartate aminotransferase activity in the supernatant of liver organ cultures on the 7th and 14th days of incubation. It was found that culturing organotypic cultures with IL-2 did not affect the synthesis function of hepatocytes, but reduced aspartate aminotransferase activity throughout the culture period. At a concentration of 7500 IU/ml IL-2 showed a weak hepatotoxic effect. It was found that erythropoietin at a medium concentration had a hepatoprotective effect, at a high concentration it suppressed the synthesis activity of hepatocytes and contributed to the destruction of the cytoplasmic membrane of cells. At low concentrations, erythropoietin increased the synthesis activity of liver cells but caused an increase in the activity of aminotransferases, this may indicate both mass cell death and intensification of amino acid transamination processes. It was established that interleukin and its inhibitor cause biological effects when incubated with organotypic cultures. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
110. The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability.
- Author
-
Geers, Bernd, Hagenstein, Julia, Endig, Jessica, Ulrich, Hanna, Fleig, Laura, Sprezyna, Paulina, Mikulec, Julita, Heukamp, Lukas, Tiegs, Gisa, and Diehl, Linda
- Subjects
- *
REGULATORY T cells , *ADP-ribosylation , *INTERLEUKIN-2 , *T cells , *CD4 antigen - Abstract
Interleukin-2 is central to the induction and maintenance of both natural (nTreg) and induced Foxp3-expressing regulatory T cells (iTreg). Thus, signals that modulate IL-2 availability may, in turn, also influence Treg homeostasis. Using global knockout and cell-specific knockout mouse models, we evaluated the role of the small GTPase ADP-ribosylation factor 4d (Arl4d) in regulatory T-cell biology. We show that the expression of Arl4d in T cells restricts both IL-2 production and responsiveness to IL-2, as measured by the phosphorylation of STAT5. Arl4d-deficient CD4 T cells converted more efficiently into Foxp3+ iTreg in vitro in the presence of αCD3ε and TGFβ, which was associated with their enhanced IL-2 secretion. As such, Arl4d−/− CD4 T cells induced significantly less colonic inflammation and lymphocytic infiltration in a model of transfer colitis. Thus, our data reveal a negative regulatory role for Arl4d in CD4 T-cell biology, limiting iTreg conversion via the restriction of IL-2 production, leading to reduced induction of Treg from conventional CD4 T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
111. Developing a translational murine‐to‐canine pathway for an IL‐2/agonist anti‐CD40 antibody cancer immunotherapy.
- Author
-
Proksch, Stephen Francis, Matthysen, Clinton Petrus, Jardine, John E., Wyatt, Ken Mark, Finlay, Jessica Renee, and Nelson, Delia Jane
- Subjects
- *
HUMAN genetic variation , *SARCOMA , *DOGS , *IMMUNOTHERAPY , *INTERLEUKIN-2 , *DOG diseases - Abstract
Human and canine sarcomas are difficult to treat soft tissue malignancies with an urgent need for new improved therapeutic options. Local recurrence rates for humans are between 10%–30%, and 30%–40% develop metastases. Outcomes for dogs with sarcoma vary with grade but can be similar. Pet dogs share the human environment and represent human cancer with genetic variation in hosts and tumours. We asked if our murine studies using genetically identical mice and cloned tumour cells were translatable to larger, genetically diverse domestic dogs with naturally occurring tumours, to (i) develop a canine cancer therapeutic, and (ii) to use as a translational pathway to humans. Our murine studies showed that intra‐tumoral delivery of interleukin‐2 (IL‐2) plus an agonist anti‐CD40 antibody (Ab) induces long‐term curative responses ranging from 30% to 100%, depending on tumour type. We developed an agonist anti‐canine‐CD40 Ab and conducted a phase I dose finding/toxicology 3 + 3 clinical trial in dogs (n = 27) with soft tissue sarcomas on account of suitability for intratumoral injection and straightforward monitoring. Dogs were treated with IL‐2 plus anti‐CD40 antibody for 2 weeks. Three dose levels induced tumour regression with minimal side effects, measured by monitoring, haematological and biochemical assays. Importantly, our mouse and canine studies provide encouraging fundamental proof‐of‐concept data upon which we can develop veterinary and human immunotherapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
112. Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression.
- Author
-
Baarz, Bastian Robinson, Laurentius, Thea, Wolf, Jana, Wessels, Inga, Bollheimer, Leo Cornelius, and Rink, Lothar
- Subjects
- *
ZINC supplements , *ZINC , *ORAL drug administration , *YOUNG adults , *REGULATOR genes , *DIETARY supplements , *PRESBYCUSIS - Abstract
Background: Aging is accompanied by a dramatic decline in the interleukin (IL)-2 production capacity of human immune cells, thus making seniors more susceptible to a variety of age-related diseases. A common cause of impaired cytokine production in advanced age is a deficiency of the essential micronutrient zinc. Nevertheless, the molecular mechanisms underlying a zinc deficiency-induced decrease in IL-2 production have not yet been satisfactorily elucidated. Recent animal and in vitro data suggested that the transcription factor cAMP-responsive element modulator (CREM) α plays a critical role in T cells´ disturbed IL-2 production in suboptimal zinc conditions. However, its role in the human aging process and the possibility of influencing this detrimental process by short-term zinc supplementation have not yet been evaluated. Results: Comparing peripheral lymphocytes of 23 young and 31 elderly subjects with either high, intermediate, or deficient zinc status, we observed zinc-dependent regulation of the IL-2 production mediated by the transcription factor CREM α . For the first time in humans, we report a mutual relationship between low zinc levels, high CREM α expression, subsequent impaired IL-2 production, and vice versa. Remarkably, an average of only 6 days of in vivo zinc supplementation to zinc-deficient seniors was sufficient to rapidly improve zinc status, reverse CREM α overexpression, and counteract subsequent low IL-2 production rates. Conclusions: Our ex vivo and in vivo data identify zinc deficiency-mediated CREM α overexpression as a key cellular mechanism underlying impaired IL-2 production in the elderly and point toward the use of zinc as a rapidly immune-enhancing add-on nutraceutical in geriatric therapy. During the aging process, there is a progressive decrease in zinc status, which in turn leads to overexpression of the transcription factor CREM α in peripheral lymphocytes. CREMα is a negative regulator of the IL-2 gene, the overexpression of which dramatically limits adequate IL-2 production. This deleterious mechanism can be counteracted by short-term oral zinc administration, which can adjust IL-2 production in old, zinc-deficient individuals to a level similar to that of young adults. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
113. Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity.
- Author
-
Mohammadi, Fateme, Hashemi, Zahra Sadat, Forooshani, Ramin Sarrami, and Alizadeh, Shaban
- Subjects
- *
LEUKEMIA treatment , *TUMOR treatment , *FLOW cytometry , *BIOMARKERS , *EXOSOMES , *CELL culture , *INTERLEUKIN-2 , *WESTERN immunoblotting , *KILLER cells , *APOPTOSIS , *BLOOD cells , *ELECTRON microscopy , *CELL survival , *GENES , *CELL lines , *COLORIMETRY , *POLYMERASE chain reaction , *CASPASES - Abstract
Background. Natural killer (NK) cells are cytotoxic lymphocytes of the innate immune system, capable of killing viral-infected and cancerous cells. NK cell-mediated immunotherapy has remarkably changed the current paradigm of cancer treatment in recent years. It emerged as a safe and effective therapeutic approach for patients with advanced-stage leukemia. Several immune-escape mechanisms can be enacted by cancer cells to avoid NK-mediated killing. Exosomes released by NK cells that carry proteins and miRNAs can exert an antitumor effect. In the present study, we hypothesized that maybe exosomes derived from trained natural killer cells show more antitumor effect in comparison to non-trained one. Methods. PBMC was separated by the Ficoll method and cultured with IL-2 for 21 days to expand NK cells. The NK cells were co-cultured with K562 for 72 hours and exosome-derived co-cultured (as trained) and natural killer cell-derived exosomes (as non-trained) were extracted by Exo kit. The exosomes were confirmed by dynamic light scattering (DLS), transmission electron microscopy (TEM), flow cytometry, and western blotting. The K562 cells were separately treated by trained and non-trained exosomes and MTT assay, apoptosis, and real-time PCR were performed. Results. Based on flow cytometry, CD56 marker was 89.7% and 40.1% for NK cells and NK-derived exosomes, respectively. CD63 and CD9 were positive for exosomes by western blotting. The morphology of exosome was confirmed by TEM. Treated K562 cells by trained exosomes indicated the diminished cell viability and higher apoptosis. Furthermore, the trained exosomes showed up-regulation in both P53 and caspase3 genes as compared with non-trained sample. Discussion. Trained Exos showed a potent inhibitory effect on proliferation and induced apoptosis on K562 cell lines compared to the same dose of non-trained Exos. According to the results of qRT-PCR, trained Exos exerted an antitumor activity through up-regulation of caspase 3 and P53 in the apoptotic signaling pathway in tumor cells. Our findings indicate an effective action of trained Exos against cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
114. Valorization of the Photo-Protective Potential of the Phytochemically Standardized Olive (Olea europaea L.) Leaf Extract in UVA-Irradiated Human Skin Fibroblasts.
- Author
-
Machała, Paulina, Liudvytska, Oleksandra, Kicel, Agnieszka, Dziedzic, Angela, Olszewska, Monika A., and Żbikowska, Halina Małgorzata
- Subjects
- *
OLIVE , *FIBROBLASTS , *OLIVE oil industry , *TUMOR necrosis factors , *OLIVE leaves , *ETHANOL , *DIETARY supplements industry - Abstract
Leaves of Olea europaea are a by-product of the olive oil industry and a dietary supplement with acknowledged antioxidant and anti-inflammatory activity but underestimated photoprotective potential. We investigated the protective effects of the LC-PDA-MS/MS standardized ethanol-water extract of olive leaves (OLE), containing 26.2% total phenols and 22.2% oleuropein, with underlying mechanisms against the UVA-induced oxidative damage in human dermal fibroblasts. Hs68 cells were pre-treated (24 h) with OLE (2.5–25 μg/mL) or the reference antioxidants, quercetin and ascorbic acid (25 μg/mL), followed by irradiation (8 J/cm2). OLE significantly reduced the UVA-induced DNA damage and reactive oxygen species (ROS) overproduction and increased the thioredoxin reductase (TrxR) expression and post-radiation viability of fibroblasts by inhibiting their apoptosis. Both intrinsic and extrinsic apoptotic signaling pathways appeared to be inhibited by OLE, but the activity of caspase 9 was the most reduced. We hypothesized that the TrxR up-regulation by OLE could have prevented the UVA-induced apoptosis of Hs68 cells. In addition, a significant decrease in UVA-induced secretion levels of tumor necrosis factor (TNF-α) and interleukin-2 (IL-2) was shown in human lymphocyte culture in response to OLE treatment. In summary, our results support the beneficial effect of OLE in an in vitro model and indicate its great potential for use in the cosmetic and pharmaceutical industry as a topical photoprotective, antioxidant, and anti-inflammatory agent. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
115. Clinical Value of Cytokine Assay in Diagnosis and Severity Assessment of Lung Cancer.
- Author
-
Ma, Jin, Zhu, Shumin, Liu, Zining, Mao, Yafei, Li, Xinyuan, Dai, Lili, Zhao, Xiaojie, Wei, Congzhen, Liu, Jinfeng, and Geng, Yulan
- Subjects
- *
INTERLEUKINS , *BIOMARKERS , *CYTOKINES , *PHYSICAL diagnosis , *SCIENTIFIC observation , *PLEURAL effusions , *BLOOD plasma , *INTERLEUKIN-2 , *LUNG tumors , *APACHE (Disease classification system) , *INTERFERONS , *SEVERITY of illness index , *CANCER patients , *RISK assessment , *TUMOR necrosis factors , *SENSITIVITY & specificity (Statistics) , *EARLY diagnosis ,MORTALITY risk factors - Abstract
Purpose. To investigate the clinical value of interleukin 2 (IL-2), interleukin 4 (IL-4), interleukin 6 (IL-6), interleukin 10 (IL-10), tumor necrosis factor α (TNF-α), and interferon-γ (IFN-γ) in diagnosis and severity assessment of lung cancer. Methods. In this observational study, 50 physical examination healthy subjects were included in the control group and 100 lung cancer patients were included in the study group. In the study group, 53 cases with pleural effusion were subgrouped to the pleural effusion group (n = 53), while 47 patients were assigned to the nonpleural effusion group (n = 47). Plasma cytokines IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of all eligible subjects were collected and compared. Results. The study group showed significantly higher levels of plasma cytokines IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ versus healthy subjects (P < 0.05). Deterioration of lung cancer was associated with increased plasma cytokine levels and APACHE II scores. The combination assay of the above plasma cytokines showed significantly better diagnostic efficacy for lung cancer versus the single assay of the cytokines. Dead patients had higher plasma cytokine levels versus survived patients. The accuracy of plasma IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ levels in the severity assessment of lung cancer was comparable with that of the APACHE II scale. Conclusion. The plasma cytokines IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ are effective markers for the diagnosis of lung cancer. The combined assay contributes to the early diagnosis of lung cancer patients, and the persistent elevation of cytokines suggests an increased risk of death in lung cancer patients, so the detection of cytokine levels facilitates the severity assessment of lung cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
116. Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren's Syndrome by 99m Tc-Interleukin-2: Diagnostic and Therapeutic Implications.
- Author
-
Campagna, Giuseppe, Anzola, Luz Kelly, Varani, Michela, Lauri, Chiara, Gentiloni Silveri, Guido, Chiurchioni, Lorenzo, Spinelli, Francesca Romana, Priori, Roberta, Conti, Fabrizio, and Signore, Alberto
- Subjects
- *
SJOGREN'S syndrome , *SALIVARY glands , *SUBMANDIBULAR gland , *SALIVARY gland cancer , *TH1 cells , *DRUG efficacy - Abstract
Background: Sjögren's syndrome (SS) is a progressive autoimmune disease characterized by local mononuclear cell infiltration of the salivary and lachrymal glands. Labial biopsy demonstrates local infiltration by Th1 cells that produce pro-inflammatory cytokines, such as interleukin-2 (IL2). The aim of this study was to assess the utility of 99mTc-labelled-IL2 (99mTc-IL2) in evaluating in vivo the extent and severity of lympho-mononuclear cell infiltration in the salivary glands of patients with SS. Methods: We investigated 48 patients with primary SS and 27 control subjects using 99mTc-IL2 scintigraphy. Furthermore, in a subgroup of 30 patients, we also performed 99mTc-pertechnetate scintigraphy (99mTcO4−) for evaluation of the salivary gland function. Results: 99mTc-IL2 uptake in the salivary glands of SS patients was higher than in the control subjects (1.30 ± 0.16 vs. 0.83 ± 0.08 for parotids and 1.36 ± 0.15 vs. 1.16 ± 0.07 for submandibular glands; p < 0.0001). The salivary gland uptake of 99mTc-IL2 in patients with a longer history of disease was lower compared with the recently diagnosed patients. A significant direct correlation was found between the uptake of 99mTc-IL2 and histology. Conclusions: 99mTc-IL2 scintigraphy showed that the degree of lymphocytic infiltration of major salivary glands is variable in patients with different disease durations. Patients with a high 99mTc-IL2 uptake could be efficiently treated with immuno-modulatory drugs and the efficacy of treatment could be followed-up by 99mTc-IL2 scintigraphy. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
117. Interleukin-2 inducible T cell kinase (ITK) may participate in the anti-bacterial immune response of Nile tilapia via regulating T-cell activation.
- Author
-
Liang, Wei, Li, Kunming, Zhang, Qian, Li, Kang, Ai, Kete, Zhang, Jiansong, Jiao, Xinying, Li, Jiaqi, Wei, Xiumei, and Yang, Jialong
- Subjects
- *
NILE tilapia , *INTERLEUKIN-2 , *IMMUNE response , *LYMPHOCYTES , *EDWARDSIELLA , *T cells - Abstract
Interleukin-2 inducible T cell kinase (ITK) plays a predominant role in the T-cell receptor (TCR) signaling cascade to ensure valid T-cell activation and function. Nevertheless, whether it regulates T-cell response of early vertebrates remains unknown. Herein, we investigated the involvement of ITK in the lymphocyte-mediated adaptive immune response, and its regulation to T-cell activation in the Nile tilapia Oreochromis niloticus. Both sequence and structure of O. niloticus ITK (OnITK) were remarkably conserved with its homologues from other vertebrates, implying its potential conserved function. OnITK mRNA was extensively expressed in lymphoid-related tissues, and with the relative highest level in peripheral blood. Once Nile tilapia was infected by Edwardsiella piscicida , OnITK in splenic lymphocytes was significantly up-regulated on 7-day post infection at both transcription and translation levels, suggesting that OnITK might involve in the primary adaptive immune response of teleost. Furthermore, upon splenic lymphocytes were stimulated by T-cell specific mitogen PHA, OnITK mRNA and protein levels were dramatically elevated. More importantly, treatment of splenic lymphocytes with specific inhibitor significantly crippled OnITK expression, which in turn impaired the inducible expression of T-cell activation markers IFN-γ, IL-2 and CD122, indicating the critical roles of ITK in regulating T-cell activation of Nile tilapia. Taken together, our results suggest that ITK takes part in the lymphocyte-mediated adaptive immunity of tilapia, and is indispensable for T-cell activation of teleost. Our findings thus provide novel evidences for understanding the mechanism regulating T-cell immunity of early vertebrates, as well as the evolution of adaptive immune system. • The mRNA of Nile tilapia ITK expresses widely in lymphoid-related tissues. • OnITK expression was induced during primary response of adaptive immunity. • ITK involves in the T-cell activation of Nile tilapia. • ITK is indispensable for T-cell activation of Nile tilapia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
118. Protein phosphatase 2A catalytic subunit β suppresses PMA/ionomycin‐induced T‐cell activation by negatively regulating PI3K/Akt signaling.
- Author
-
Gao, Rui, Li, Xin, Gao, Huiying, Zhao, Ke, Liu, Xian, Liu, Jinfang, Wang, Qi, Zhu, Yaxin, Chen, Hui, Xiang, Shensi, Zhan, Yiqun, Yin, Ronghua, Yu, Miao, Ning, Hongmei, Yang, Xiaoming, and Li, Changyan
- Subjects
- *
PI3K/AKT pathway , *PHOSPHOPROTEIN phosphatases , *TUMOR necrosis factors , *INTERLEUKIN-2 , *CELL proliferation , *INTERLEUKIN-7 - Abstract
The precise regulation of the T‐cell activation process is critical for overall immune homeostasis. Although protein phosphatase 2A (PP2A) is required for T‐cell development and function, the role of PPP2CB, which is the catalytic subunit β isoform of PP2A, remains unknown. In the present study, using a T cell‐specific knockout mouse of PPP2CB (PPP2CBfl/fl Lck‐Cre+), we demonstrated that PPP2CB was dispensable for T‐cell development in the thymus and peripheral lymphoid organs. Furthermore, PPP2CB deletion did not affect T‐cell receptor (TCR)‐induced T‐cell activation or cytokine‐induced T‐cell responses; however, it specifically enhanced phorbol myristate acetate (PMA) plus ionomycin‐induced T‐cell activation with increased cellular proliferation, elevated CD69 and CD25 expression, and enhanced cytokine production (inteferon‐γ, interleukin‐2 and tumor necrosis factor). Mechanistic analyses suggested that the PPP2CB deletion enhanced activation of the phosphoinositide 3‐kinase/Akt signaling pathway and Ca2+ flux following stimulation with PMA plus ionomycin. Moreover, the specific PI3K inhibitor rescued the augmented cell activation in PPP2CB‐deficient T cells. Using mass spectrometry‐based phospho‐peptide analysis, we identified potential substrates of PPP2CB during PMA plus ionomycin‐induced T‐cell activation. Collectively, our study provides evidence of the specific role of PPP2CB in controlling PMA plus ionomycin‐induced T‐cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
119. 日粮添加复合益生菌对肉鸡生长性能、免疫功能及肠道健康的影响.
- Author
-
孟小林, 祁巧芬, 陈英, and 赵永旭
- Subjects
- *
IMMUNOGLOBULIN M , *DIETARY supplements , *BROILER chickens , *PROBIOTICS , *INTERLEUKIN-2 , *INTERLEUKIN-10 , *BODY weight - Abstract
The experiment was to study the effect of different levels of compound probiotics on growth performance, immune function and intestinal health of AA broilers. A total of 1 200 AA broiler chickens were selected and randomly divided into four groups, with ten replicates in each group and 30 broilers in each replicate. The AA broilers in each group were fed with a basal diet supplement with 0 (control group), 0.1% (group 1), 0.2% (group 2) and 0.4% (group 3) of compound probiotics, respectively. The trial period was 6 w. The results showed that compared with control group, the body weight at 42 d and the average daily gain at 1~42 d of AA broilers in group 2 and group 3 were significantly increased (P<0.05), and feed to gain ratio was significantly decreased (P<0.05). Compared with control group, at the age of 42 d, the spleen index and thymus index of AA broilers in group 2 and group 3 were significantly increased (P<0.05). Compared with control group, the serum levels of immunoglobulin M (IgM) and secreted immunoglobulin A (sIgA) in AA broilers in each test group were significantly increased (P<0.05), and the content of tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2) were significantly decreased (P<0.05), the content of interleukin-10 (IL-10) was significantly increased (P<0.05). The content of interleukin-6 (IL-6) in the serum of AA broilers in group 2 and group 3 was significantly decreased (P<0.05). Compared with control group, the villus height and villus to crypto ratio of duodenum of AA broilers in group 2 and group 3 were significantly increased (P<0.05). The study indicates that adding an appropriate amount of compound probiotics to diet can improve the growth performance, immune function and intestinal health of AA broilers, and the optimum addition amount is 0.2%. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
120. Effect of IL-2 polymorphism rs2069762 on single-unit cord blood transplant outcomes.
- Author
-
Konuma, Takaaki, Hamatani-Asakura, Megumi, Monna-Oiwa, Maki, Kato, Seiko, Isobe, Masamichi, Yokoyama, Kazuaki, Takahashi, Satoshi, and Nannya, Yasuhito
- Subjects
- *
CORD blood , *CORD blood transplantation , *TREATMENT effectiveness , *KILLER cells , *HEMATOPOIETIC stem cell transplantation , *CYTOTOXIC T cells - Abstract
Interleukin-2 (IL-2) is one of the most important cytokines that regulate the activation and proliferation of T cells and natural killer cells. The production of IL-2 may be affected by polymorphisms in the promoter region of the IL-2 gene (rs2069762). In allogeneic hematopoietic cell transplantation (HCT) from adult donors, rs2069762 has been associated with the incidence of acute and chronic graft-versus-host disease (GVHD). However, the impacts of IL-2 polymorphism on cord blood transplantation (CBT) outcomes remain unclear. The objective of this study was to assess the impact of IL-2 polymorphism rs2069762 on transplant outcomes, such as hematopoietic recovery, GVHD, overall survival, relapse, and non-relapse mortality (NRM) after CBT. We conducted a retrospective analysis of data from adult patients who underwent single-unit CBT at our institution from November 2005 to March 2023 for whom DNA samples from recipients and donors were available. IL-2 genotyping was performed using real-time polymerase chain reaction with the TaqMan® SNP genotyping assay for rs2069762. A total of 143 recipient and donor pairs were included in this study. The proportion of recipient IL-2 polymorphism rs2069762 was 48 % (n = 69) for AA, 42 % (n = 60) for CA, and 10 % (n = 14) for CC. The proportion of donor IL-2 polymorphism rs2069762 was 43 % (n = 61) for AA, 48 % (n = 69) for CA, and 9 % (n = 13) for CC. In the multivariate analysis, the use of an rs2069762 CA + CC donor was associated with lower neutrophil recovery compared to an rs2069762 AA donor (hazard ratio [HR], 0.66; 95 % confidence interval [CI], 0.50–0.88; P = 0.004). Furthermore, recipients of rs2069762 CA + CC were associated with higher NRM compared to recipients of rs2069762 AA (HR, 2.32; 95 % CI, 1.01–5.34; P = 0.047). Serum IL-2 levels at 8 weeks were significantly higher in rs2069762 CA + CC recipients compared to those with rs2069762 AA recipients (P = 0.014). Our data showed that donor IL-2 polymorphism affects neutrophil recovery and recipient IL-2 polymorphism affects NRM in adults undergoing single-unit CBT. The polymorphism of IL-2 rs2069762 in recipients and donors might be associated with the clinical outcomes of single-unit CBT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
121. Targeting the aryl hydrocarbon receptor with FICZ regulates IL-2 and immune infiltration to alleviate Hashimoto's thyroiditis in mice.
- Author
-
Liao, Zhengzheng, Zeng, Xianzhong, Guo, Xiaoling, Shi, Qing, Tang, Ziyun, Li, Ping, Chen, Cuiyun, Chen, Mengxia, Chen, Jianrong, Xu, Jixiong, and Cai, Yaojun
- Subjects
- *
AUTOIMMUNE thyroiditis , *ARYL hydrocarbon receptors , *EPITHELIAL cell culture , *CYTOTOXIC T cells , *OVARIAN follicle , *THYROTROPIN receptors , *AUTOIMMUNE diseases - Abstract
Hashimoto's thyroiditis (HT) is the most frequent autoimmune disorder. Growing work points to the involvement of aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, in the regulation of immune homeostasis. However, the roles of AhR and its ligands in HT remains unclear. In this study, we leveraged public human database analyses to postulate that the AhR expression was predominantly in thyroid follicular cells, correlating significantly with the thyroid infiltration levels of multiple immune cells in HT patients. Using a thyroglobulin-induced HT mouse model and in vitro thyroid follicular epithelial cell cultures, we found a significant downregulation of AhR expression in thyrocytes both in vivo and in vitro. Conversely, activating AhR by FICZ, a natural AhR ligand, mitigated inflammation and apoptosis in thyrocytes in vitro and conferred protection against HT in mice. RNA sequencing (RNA-seq) of thyroid tissues indicated that AhR activation moderated HT-associated immune or inflammatory signatures. Further, immunoinfiltration analysis indicated that AhR activation regulated immune cell infiltration in the thyroid of HT mice, such as suppressing cytotoxic CD8+ T cell infiltration and promoting anti-inflammatory M2 macrophage polarization. Concomitantly, the expression levels of interleukin-2 (IL-2), a lymphokine that downregulates immune responses, were typically decreased in HT but restored upon AhR activation. In silico validation substantiated the binding interaction between AhR and IL-2. In conclusion, targeting the AhR with FICZ regulates IL-2 and immune infiltration to alleviate experimental HT, shedding new light on the therapeutic intervention of this prevalent disease. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
122. Modulatory effect of interleukin-2 loaded chitosan nano sphere on regulatory T cell activity in streptozotocin-induced diabetic mice.
- Author
-
Aboelnazar, Salma, Ghoneim, Hossam, Shalaby, Thanaa, Sorour, Sally, and Osman, Eman M.
- Subjects
- *
REGULATORY T cells , *STREPTOZOTOCIN , *FORKHEAD transcription factors , *TRANSFORMING growth factors-beta , *T cells , *INTERLEUKIN-2 , *CHITOSAN - Abstract
• Experimental induction of T1D was performed in male inbred Balb/c mice using strptozotocin. • Free recombinant IL-2 decreased glucose levels in treated mice. • Recombinant IL-2 encapsulated in chitosan nanoparticles exhibited prolonged glucose-lowering capacity. • Encapsulated IL-2 increases the level of FoxP3 (regulatory T cell marker. • TGFβ levels were significantly increased after chitosan the treatment with nanoparticles-containing IL-2. The current study aimed to assess the modulating effect of IL-2 encapsulated chitosan-nanoparticles (CSNPs) on the function of Treg cells through induction of type 1 diabetes (T1D). Treg cell function was monitored by the forkhead box P3 (FoxP3) and transforming growth factor beta (TGFβ) levels, correlating them with blood glucose and serum insulin levels. In this case-control study, a low dose of IL-2 (free and chitosan-loaded) was injected into a diabetic mice group. The levels of FoxP3 and TGF-β 1 were assessed using Enzyme-Linked Immunosorbent Assay. In addition, blood glucose and serum insulin levels were determined. The mean glucose level decreased significantly after free rIL-2 or rIL-2 / CSNPs treatment. Meanwhile, the mean serum insulin level was significantly increased after treatment with free rIL-2 or rIL-2/CSNPs. The mean levels of FoxP3 and TGFβ 1 were significantly increased with either free rIL-2 or rIL-2/CSNPs compared to the T1D untreated group (P < 0.001). In the treated mice group receiving free CSNPs, there was a significant negative correlation between glucose and insulin levels. Moreover, FoxP3 & TGFβ 1 levels had a significant positive correlation. In treated mice groups with free rIL-2 and IL-2 CSNPs, there was a significant positive correlation between FoxP3 and glucose levels. A significant negative correlation was found after conducting a correlation between insulin level and FoxP3 in the T1D/ rIL-2 / CSNPs group. Low-dose IL-2 selectively modulates FoxP3 + Tregs, and TGFβ 1 increases their levels. These results demonstrated that IL-2-free and chitosan-loaded nanoparticles can be therapeutic agents in T1D. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
123. Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease.
- Author
-
Liao, Yunfei, Ke, Ben, Long, Xiaoyan, Xu, Jianjun, and Wu, Yongbing
- Subjects
- *
MUCOCUTANEOUS lymph node syndrome diagnosis , *BIOMARKERS , *RESEARCH , *INTERLEUKIN-2 , *CELL physiology , *GENE expression , *GENES , *MUCOCUTANEOUS lymph node syndrome , *STATISTICAL correlation , *LOGISTIC regression analysis , *T cells , *ALGORITHMS - Abstract
Aims. The clinical diagnosis of Kawasaki disease (KD) is not easy because of many atypical manifestations. This study is aimed at finding potential diagnostic markers and therapeutic targets for KD and analysing their correlation with immune cell infiltrations. Methods. First, we downloaded the KD dataset from the Gene Expression Omnibus (GEO) database and used R software to identify differentially expressed genes (DEGs) and perform functional correlation analysis. Then, CIBERSORT algorithm was used to evaluate immune cell infiltrations in samples. Coexpression analysis between DEGs and infiltrating immune cells was performed to screen the main infiltrating immune cells. Subsequently, the least absolute shrinkage and selection operator (LASSO) logistic regression analysis was used to screen the core genes related to KD. Finally, correlation analysis between the core genes and the main infiltrating immune cells was performed. Results. 327 DEGs were screened out in this study. Among them, 72 shared genes were the category of genes most likely to be disease-causing for they did not change before and after treatment. After analysis, it was found that expression level of IL2RB in KD tissues was significantly upregulated, the number of resting CD4+ memory T cells was decreased, and the decrease was significantly negatively correlated with the upregulated expression of IL2RB. Therefore, it was speculated that the upregulated expression of IL2RB disrupted Th1/Th2 cell differentiation balance, which led to a decrease of resting CD4+ memory T cells and finally caused disorder of immune microenvironment in patients with KD. Conclusions. Upregulated expression of IL2RB leads to disorder of immune microenvironment in patients with KD and eventually causes the occurrence and development of KD. Therefore, IL2RB may serve as a diagnostic marker and potential therapeutic target for KD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
124. A Novel Technique for the Generation of Substantial Numbers of Functional Resident T Cells from Kidney Tissue.
- Author
-
Betjes, Michiel G. H., Prevoo, Frederique, van den Bosch, Thierry P. P., Klepper, Mariska, and Litjens, Nicolle H. R.
- Subjects
- *
TISSUE culture , *RENAL biopsy , *KIDNEYS , *T cells , *FLOW cytometry , *CELL proliferation - Abstract
Studying functionality and antigen-specificity of resident kidney T cells derived from a kidney biopsy is hampered by the lack of sufficient numbers of T cells obtained by the standard method of enzymatic tissue dissociation. Enzymatic dissociation of kidney tissue was compared to a novel method of whole kidney tissue culture allowing T cells to migrate into the medium in the presence of exogenous IL-2 and IL-15. T cell numbers were quantified and phenotype of resident T cells (CD69+CD103+/−), TCR Vβ repertoire and functional characteristics were analyzed with multi-parameter flow cytometry. Renal tissue culture for four weeks in the presence of exogenous IL-2 and IL-15 yielded significantly higher numbers of T cells (1.3 × 104/mm3) when compared to cultures without exogenous cytokines (71/mm3) or direct isolation by enzymatic dissociation (662/mm3 T cells, p < 0.05). The proportion of T cells with a resident phenotype did not change in the tissue culture; percentages amounted to 87.2% and 85.1%, respectively. In addition, frequencies of CD4+, CD8+, CD4−CD8−, T cells and MAIT T cells remained similar. For both CD4+ and CD8+, T cells had a more differentiated memory phenotype after tissue culture, but the distribution of TCR Vβ families did not change. In addition, the predominant Th1 cytokine secretion profile and poly-functionality of resident kidney T cell remained intact. T cell proliferation potential was not affected, excluding exhaustion and enrichment of BKV- and CMV-reactive resident T cells was observed. In conclusion, the kidney tissue culture method yields significantly increased numbers of resident T cells without major effects on composition and functionality. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
125. Therapeutic potential of interleukin-2 in autoimmune diseases.
- Author
-
Yuan, Yeshuang, Kolios, Antonios G.A., Liu, Yudong, Zhang, Bo, Li, Hao, Tsokos, George C., and Zhang, Xuan
- Abstract
Autoimmune diseases are characterized by dysregulation and aberrant activation of cells in the immune system. Therefore, restoration of the immune balance represents a promising therapeutic target in autoimmune diseases. Interleukin-2 (IL-2) can promote the expansion and differentiation of different immune cell subsets dose-dependently. At high doses, IL-2 can promote the differentiation and expansion of effector and memory T cells, whereas at low doses, IL-2 can promote the differentiation, survival, and function of regulatory T (T reg) cells, a CD4+ T cell subset that is essential for the maintenance of immune homeostasis and immune tolerance. Therefore, IL-2 exerts immunostimulatory and immunosuppressive effects in autoimmune diseases. The immunoregulatory role of low-dose IL-2 has sparked excitement for the therapeutic exploration of modulating the IL-2-T reg axis in the context of autoimmune diseases. In this review, we discuss recent advances in the therapeutic potential of IL-2 or IL-2-derived molecules in the treatment of autoimmune diseases. Current treatment concepts of autoimmune diseases are based on broad or specific inhibition of disease pathways, commonly associated with side effects. Defective regulatory T (T reg) cells are increasingly recognized as a pathogenic hallmark of autoimmune diseases and their stimulation with interleukin-2 (IL-2) offers an important novel approach in restoration of the immune balance and, therefore, their use in treatment. IL-2, in low doses, has the ability to preferentially induce T reg cells without activating autoreactive effector T cells (T eff); this makes it a promising therapeutic tool for autoimmune diseases, but further development of IL-2 formulations with longer half-life, more specific T reg cell induction, and reduced immunogenicity is even more encouraging. Plenty of indications and clinical trials are underway to prove or evaluate the potential of IL-2 in an increasing number of indications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
126. A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses.
- Author
-
Agrez, Michael, Rzepecka, Justyna, Turner, Darryl, Knox, Gavin, Chandler, Christopher, Howard, Christopher B., Fletcher, Nicholas, Thurecht, Kristofer, Parker, Stephen, Gooding, Hayley, and Gallagher, Laura
- Subjects
- *
REGULATORY T cells , *PEPTIDES , *T cells , *INTERLEUKIN-2 , *CELLULAR signal transduction - Abstract
T cell-dendritic cell (DC) interactions contribute to reciprocal stimulation leading to DC maturation that results in production of interleukin-12 (IL-12) and interferon-gamma (IFN-γ). Both cytokines have been implicated in autoimmune diseases while being necessary for effective immune responses against foreign antigens. We describe a lipidic peptide, designated IK14004, that modifies crosstalk between T cells and DCs resulting in suppression of IL-12p40/IFN-γ production. T cell production of interleukin-2 (IL-2) and IFN-γ is uncoupled and IL-12p70 production is enhanced. IK14004 induces expression of activating co-receptors in CD8+ T cells and increases the proportion of Foxp3-expressing CD4+ T regulatory cells. The potential for IK14004 to impact on signalling pathways required to achieve a balanced immune response upon stimulation of DCs and T cells is highlighted. This novel compound provides an opportunity to gain further insights into the complexity of T cell-DC interactions relevant to autoimmunity associated with malignancies and may have therapeutic benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
127. 重组人酸性成纤维细胞生长因子联合夫西地酸乳膏 局部应用对深Ⅱ度烧伤的影响.
- Author
-
李亮, 王旭文, 何丽彩, 李双, 蔺利剑, 赵龙刚, and 李雯
- Subjects
- *
FIBROBLAST growth factors , *WOUND healing , *INTERLEUKIN-2 , *INTERLEUKIN-10 , *HYPERTROPHIC scars - Abstract
Objective To observe the effect of recombinant human acidic fibroblast growth factor combined with fusidic acid cream on patients with deep second-degree burn. Methods From June 2019 to May 2020, 120 patients with deep second-degree burn were selected as the research subjects. All patients were randomly divided into control group 1, control group 2 and observation group, 40 cases in each group. In control group 1, patients were treated with scab ablation combined with recombinant human acidic fibroblast growth factor. In control group 2, patients were treated with scab ablation combined with fusidic acid cream. In the observation group, patients were treated with scab ablation, recombinant human acidic fibroblast growth factor and fusidic acid cream. All patients in 3 groups were treated continuously until wound healing. The interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), tissue inhibitor of metalloproteinase-1 (TIMP-1) and transforming growth factor-α1 (TGF-α1) were measured before and 20 days after treatment. The wound healing time was observed, the degree of scar hyperplasia in 3 groups was evaluated by Vancouver Scar Scale (VSS) and the adverse reactions were recorded. Results The level of TNF-α and IL-6 in observation group was lower than that in control group 1 and 2 (P<0.05), the level of IL-2 and IL-10 in observation group was higher than that in control group 1 and 2 (P<0.05), and the level of VEGF, EGF, TIMP-1 and TGF-α1 in observation group was higher than that in control group 1 and 2 (P<0.05). At 10, 15 and 20 days of treatment, the wound healing rate in observation group was higher than that of control group 1 and 2 (P<0.05), and the average wound healing time of observation group was shorter than that of control group 1 and 2 (P<0.05). The scores of vascular distribution, color, thickness and softness of scar in observation group was lower than those of control group 1 and 2 (P<0.05). No obvious adverse reactions occurred in 3 groups. Conclusion Application of recombinant human acidic fibroblast growth factor combined with fusidic acid cream in the treatment of deep second-degree burn can reduce the level of pro-inflammatory factors of TNF-α and IL-6, increase the level of anti-inflammatory factors of IL-2 and IL-10, inhibit inflammation, increase the level of VEGF, EGF, TIMP-1 and TGF-α1, improve wound healing rate and reduce scar hyperplasia. The safety was high. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
128. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression.
- Author
-
Chen, Hao, Tang, Chao, Tan, Chun, Wu, Fei, Li, Zhenhan, Ji, Wenyan, Lu, Linming, Xu, Chongjun, Shen, Zhengchao, and Huang, Yanqiang
- Subjects
- *
HEPATOCELLULAR carcinoma , *EXOSOMES , *MICRORNA , *INTERLEUKIN-2 , *CELL proliferation - Abstract
Background. Interleukin-2 (IL-2) is proved to play an irreplaceable role in antitumor regulation in numerous experimental and clinical trials. Tumor-associated macrophages (TAMs) are able to release exosomes to promote the development and progression of hepatocellular carcinoma (HCC) as essential component of microenvironment. In this study, our intention is to explore the effects of the exosomes from TAMs with IL-2 treatment on HCC development. TAMs were collected and cultured from HCC tissues. The exosomes from the TAMs treated with IL-2 (ExoIL2-TAM) or not (ExoTAM) were identified and used to treat HCC cells in vivo and in vitro. The proliferation, apoptosis, and metastasis of HCC cells were measured. The changes of miRNAs in exosomes were explored to clarify the possible mechanisms. Both decrease of cell proliferation and metastasis and increase of apoptosis were observed with ExoIL2-TAM treatment compared with ExoTAMin vivo and in vitro. miR-375 was obviously augmented in ExoIL2-TAM and HCC cells treated with ExoIL2-TAM. Taken together, IL-2 may modulate exosomal miRNAs from TAMs to ameliorate hepatocellular carcinoma development. This study provides a new perspective to explain the mechanism by which IL-2 inhibits hepatocellular carcinoma and implies the potential clinical value of exosomal miRNAs released by TAMs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
129. Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry.
- Author
-
Faouzi, Malika, Wakano, Clay, Monteilh-Zoller, Mahealani K, Neupane, Ram P, Starkus, John G, Neupane, Jayanti Bhandari, Cullen, Aaron J, Johnson, Brandon E, Fleig, Andrea, and Penner, Reinhold
- Subjects
- *
CANNABINOID receptors , *CANNABINOIDS , *NUCLEAR factor of activated T-cells , *CARBOXYLIC acid derivatives , *CALCIUM , *T cells - Abstract
Cannabis sativa has long been known to affect numerous biological activities. Although plant extracts, purified cannabinoids, or synthetic cannabinoid analogs have shown therapeutic potential in pain, inflammation, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting, the underlying mechanisms of action remain ill-defined. In this study we provide the first comprehensive overview of the effects of whole-plant Cannabis extracts and various pure cannabinoids on store-operated calcium (Ca2+) entry (SOCE) in several different immune cell lines. Store-operated Ca2+ entry is one of the most significant Ca2+ influx mechanisms in immune cells, and it is critical for the activation of T lymphocytes, leading to the release of proinflammatory cytokines and mediating inflammation and T cell proliferation, key mechanisms for maintaining chronic pain. While the two major cannabinoids cannabidiol and trans-Δ9-tetrahydrocannabinol were largely ineffective in inhibiting SOCE, we report for the first time that several minor cannabinoids, mainly the carboxylic acid derivatives and particularly cannabigerolic acid, demonstrated high potency against SOCE by blocking calcium release-activated calcium currents. Moreover, we show that this inhibition of SOCE resulted in a decrease of nuclear factor of activated T-cells activation and Interleukin 2 production in human T lymphocytes. Taken together, these results indicate that cannabinoid-mediated inhibition of a proinflammatory target such as SOCE may at least partially explain the anti-inflammatory and analgesic effects of Cannabis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
130. The metalloprotease ADAM10 generates soluble interleukin-2 receptor alpha (sCD25) in vivo.
- Author
-
Kirschke, Sophia, Ogunsulire, Ireti, Selvakumar, Balachandar, Schumacher, Neele, Sezin, Tanya, Rose-John, Stefan, Scheffold, Alexander, Garbers, Christoph, and Lokau, Juliane
- Subjects
- *
INTERLEUKIN-2 , *T cells , *CELL differentiation , *CELLULAR signal transduction , *PROTEOLYTIC enzymes , *METALLOPROTEINASES - Abstract
The cytokine interleukin-2 (IL-2) plays a critical role in controlling the immune homeostasis by regulating the proliferation and differentiation of immune cells, especially T cells. IL-2 signaling is mediated via the IL-2 receptor (IL-2R) complex, which consists of the IL-2Rα (CD25), the IL-2Rβ, and the IL-2Rγ. While the latter are required for signal transduction, IL-2Rα controls the ligand-binding affinity of the receptor complex. A soluble form of the IL-2Rα (sIL-2Rα) is found constitutively in human serum, though its levels are increased under various pathophysiological conditions. The sIL-2Rα originates partly from activated T cells through proteolytic cleavage, but neither the responsible proteases nor stimuli that lead to IL-2Rα cleavage are known. Here, we show that the metalloproteases ADAM10 and ADAM17 can cleave the IL- 2Rα and generate a soluble ectodomain, which functions as a decoy receptor that inhibits IL-2 signaling in T cells. We demonstrate that ADAM10 is mainly responsible for constitutive shedding of the IL-2Rα, while ADAM17 is involved in IL- 2Rα cleavage upon T cell activation. In vivo, we found that mice with a CD4-specific deletion of ADAM10, but not ADAM17, show reduced steady-state sIL-2Rα serum levels. We propose that the identification of proteases involved in sIL-2Rα generation will allow for manipulation of IL-2Rα cleavage, especially as constitutive and induced cleavage of IL-2Rα are executed by different proteases, and thus offer a novel opportunity to alter IL-2 function. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
131. Extraction and evaluation of biological activities of a polysaccharide from Allium mongolicum Regel.
- Author
-
Ruiping Hu, Songyao Xu, Changjin Ao, Yanhua Ma, Hashen Bao, Shumei Ye, Jitao Sun, Hong Yuan, Huiting Xue, and Chunli Ma
- Subjects
- *
POLYSACCHARIDES , *ALLIUM , *IMMUNOMODULATORS , *PERITONEAL macrophages , *INTERLEUKIN-2 , *STAPHYLOCOCCUS aureus , *T cells - Abstract
Allium mongolicum Regel polysaccharide (AMRP) acts as a main active substance of A. mongolicum Regel, but its structure and function are not fully understood. In this study, the AMRP fraction, AMRP-2 consisting of GalA, Rha, Glc, and Gal, was isolated and characterized. The antibacterial activity of AMRP-2 evaluated with the cup-plate method had a weak inhibitory effect against Staphylococcus aureus, Staphylococcus albus, Pseudomonas aeruginosa, and Proteus vulgaris, but Escherichia coli and Shigella dysenteriae were relatively sensitive to AMRP-2. Furthermore, the immunoregulatory effects of AMRP-2 were evaluated both in vitro and in vivo. The results showed that after intragastric administration of AMRP-2, the proliferation of splenic T cells and the phagocytosis of peritoneal macrophages in mice were significantly enhanced, and the interleukin-2 (IL-2) and tumour necrosis factors α (TNF-α) levels in serum also increased sharply compared to the control group. These in vivo results were consistent with those of the in vitro study, i.e., splenic T cells proliferated dramatically after AMRP-2 treatment, and the secretion of IL-2 from mouse splenic T cells and TNF-α from peritoneal macrophages increased significantly. These findings indicated that AMRP-2 is an important immune modulator that has potential as an immunotherapy drug. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
132. Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study.
- Author
-
Lagan, Jakub, Naish, Josephine H., Fortune, Christien, Campbell, Christopher, Chow, Shien, Pillai, Manon, Bradley, Joshua, Francis, Lenin, Clark, David, Macnab, Anita, Nucifora, Gaetano, Dobson, Rebecca, Schelbert, Erik B., Schmitt, Matthias, Hawkins, Robert, and Miller, Christopher A.
- Subjects
- *
MAGNETIC resonance imaging , *INTERLEUKIN-2 , *MAGNETOTHERAPY , *DIAGNOSTIC imaging , *VENTRICULAR ejection fraction - Abstract
High dose interleukin-2 (IL-2) is known to be associated with cardiopulmonary toxicity. The goal of this study was to evaluate the effects of high dose IL-2 therapy on cardiopulmonary structure and function. Combined cardiopulmonary magnetic resonance imaging (MRI) was performed in 7 patients in the acute period following IL-2 therapy and repeated in 4 patients in the chronic period. Comparison was made to 10 healthy volunteers. IL-2 therapy was associated with myocardial and pulmonary capillary leak, tissue oedema and cardiomyocyte injury, which resulted in acute significant left ventricular (LV) dilatation, a reduction in LV ejection fraction (EF), an increase in LV mass and a prolongation of QT interval. The acute effects occurred irrespective of symptoms. In the chronic period many of the effects resolved, but LV hypertrophy ensued, driven by focal replacement and diffuse interstitial myocardial fibrosis and increased cardiomyocyte mass. In conclusion, IL-2 therapy is ubiquitously associated with acute cardiopulmonary inflammation, irrespective of symptoms, which leads to acute LV dilatation and dysfunction, increased LV mass and QT interval prolongation. Most of these effects are reversible but IL-2 therapy is associated with chronic LV hypertrophy, driven by interstitial myocardial fibrosis and increased cardiomyocyte mass. The findings have important implications for the monitoring and long term impact of newer immunotherapies. Future studies are needed to improve risk stratification and develop cardiopulmonary-protective strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
133. Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer.
- Author
-
Chatzkel, Jonathan, Schell, Michael J., Chahoud, Jad, Jingsong Zhang, Jain, Rohit, Swank, Jennifer, Ludlow, Steve, Lombardi, Kristina, Lucas, Yesenia, Croft, Cortlin, Rembisz, Jennifer, Jameel, Gigi, and Fishman, Mayer
- Subjects
- *
PEMBROLIZUMAB , *INTERLEUKIN-2 , *RENAL cancer treatment , *IMMUNE checkpoint inhibitors , *LYMPHOCYTES - Abstract
Pharmacologic ligation of the interleukin-2 receptor and immune checkpoint blockade may change lymphocytes to induce regression of various cancers. This study addressed the safety and feasibility of the combination of interleukin-2 and pembrolizumab in the treatment of metastatic clear cell renal cancer. Nineteen out of twenty-seven patients had partial or complete responses. No accrual stops for safety were triggered. Introduction: The ligation of the interleukin-2 (IL-2) receptor and immune checkpoint blockade may each alter lymphocytes, thereby inducing regression in various cancers. Single agent objective response rates of 14% to 25% have been reported for usual schedule 14-dose-in-a-row IL-2 therapy of metastatic clear cell renal cancer (ccRCC), with a notable subset of responses being durable. Pembrolizumab yielded a 33% response rate in patients with metastatic ccRCC. Patients and Methods: This study addressed the safety and feasibility of the combination of IL-2 and pembrolizumab in the treatment of metastatic ccRCC. Subjects were treated with four 9-week blocks of therapy, receiving pembrolizumab every 3 weeks in all blocks and receiving 4 courses of 5-planned-doses high dose IL-2 in each of blocks 2 and 3. Safety was monitored by a Pocock boundary of study suspension and re-evaluation if exceeding a 15% dose limiting toxicity rate at a = 0.05. The Simon 2-stage design tested for an alternative hypothesis response rate of at least a 45% vs. a null hypothesis rate of less than 20%, with a = 0.10 and 90% power Results: No accrual suspension for safety was triggered. The objective response rate was 70% (19/27, 95% CI: 0.50-0.86). Nine patients responded after pembrolizumab alone and ten responded after the addition of IL-2. At a minimum follow-up of 23 months, 9 of the responding patients had no disease progression requiring additional treatment. Conclusion: The combination of 5-planned-dose-schedule high dose IL-2 and pembrolizumab is feasible, with a high response rate, justifying further exploration of this dual immune treatment of metastatic ccRCC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
134. Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.
- Author
-
Shapiro, Roman M., Birch, Grace C., Guangan Hu, Cadavid, Juliana Vergara, Nikiforow, Sarah, Baginska, Joanna, Ali, Alaa K., Tarannum, Mubin, Sheffer, Michal, Abdulhamid, Yasmin Z., Rambaldi, Benedetta, Arihara, Yohei, Reynolds, Carol, Halpern, Max S., Rodig, Scott J., Cullen, Nicole, Wolff, Jacquelyn O., Pfaff, L., Lane, Andrew A., and Lindsley, R. Coleman
- Subjects
- *
HOMOGRAFTS , *INTERLEUKIN-2 , *KILLER cells , *DISEASE relapse , *RESEARCH funding , *HEMATOPOIETIC stem cell transplantation - Abstract
BackgroundResponses to conventional donor lymphocyte infusion for postallogeneic hematopoietic cell transplantation (HCT) relapse are typically poor. Natural killer (NK) cell-based therapy is a promising modality to treat post-HCT relapse.MethodsWe initiated this ongoing phase I trial of adoptively transferred cytokine-induced memory-like (CIML) NK cells in patients with myeloid malignancies who relapsed after haploidentical HCT. All patients received a donor-derived NK cell dose of 5 to 10 million cells/kg after lymphodepleting chemotherapy, followed by systemic IL-2 for 7 doses. High-resolution profiling with mass cytometry and single-cell RNA sequencing characterized the expanding and persistent NK cell subpopulations in a longitudinal manner after infusion.ResultsIn the first 6 enrolled patients on the trial, infusion of CIML NK cells led to a rapid 10- to 50-fold in vivo expansion that was sustained over months. The infusion was well tolerated, with fever and pancytopenia as the most common adverse events. Expansion of NK cells was distinct from IL-2 effects on endogenous post-HCT NK cells, and not dependent on CMV viremia. Immunophenotypic and transcriptional profiling revealed a dynamic evolution of the activated CIML NK cell phenotype, superimposed on the natural variation in donor NK cell repertoires.ConclusionGiven their rapid expansion and long-term persistence in an immune-compatible environment, CIML NK cells serve as a promising platform for the treatment of posttransplant relapse of myeloid disease. Further characterization of their unique in vivo biology and interaction with both T cells and tumor targets will lead to improvements in cell-based immunotherapies.Trial RegistrationClinicalTrials.gov NCT04024761.FundingDunkin' Donuts, NIH/National Cancer Institute, and the Leukemia and Lymphoma Society. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
135. Delirium due to hip fracture is associated with activated immune-inflammatory pathways and a reduction in negative immunoregulatory mechanisms.
- Author
-
Thisayakorn, Paul, Thipakorn, Yanin, Tantavisut, Saran, Sirivichayakul, Sunee, and Maes, Michael
- Subjects
- *
INTERLEUKIN-2 , *HIP fractures , *PATIENT Activation Measure , *IMMUNOSUPPRESSION , *DELIRIUM , *T helper cells , *OLDER people , *OLDER patients - Abstract
Background: The objectives of this study were to delineate whether delirium in older adults is associated with activation of the immune-inflammatory response system (IRS) as indicated by activation of M1, T helper (Th)1, and Th17 profiles, and/or by reduced activities of the compensatory immunoregulatory system (CIRS), including Th2 and T regulatory profiles. Methods: We recruited 65 older adult patients with a low energy impact hip fracture who underwent hip fracture operation. The CAM-ICU and the Delirium Rating Scale, Revised-98-Thai version (DRS-R-98) were assessed pre-operatively and 1, 2 and 3 days after surgery. Blood samples (day 1 and 2) post-surgery were assayed for cytokines/chemokines using a MultiPlex assay and the neutrophil/lymphocyte ratio. Results: We found that delirium and/or the DRS-R-98 score were associated with IRS activation as indicated by activated M1, Th1, Th17 and T cell growth profiles and by attenuated CIRS functions. The most important IRS biomarkers were CXCL8, interleukin (IL)-6, and tumor necrosis factor-α, and the most important CIRS biomarkers were IL-4 and soluble IL-1 receptor antagonist. We found that 42.5% of the variance in the actual changes in the DRS-R-98 score (averaged from day 1 to day 3) was explained by T cell growth factors, baseline DRS-R-98 scores and age. An increase in the NLR reflects overall IRS, M1, Th1, Th17, and Th2 activation. Conclusions: Post-hip surgery delirium is associated with activated IRS pathways and appears especially in patients with lowered CIRS functions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
136. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
- Author
-
Chang, Guodong, Chen, Yingwei, Liu, Zichang, Wang, Yong, Ge, Wenkun, Kang, Yongan, and Guo, Shuling
- Subjects
- *
ATRIAL fibrillation , *T cells , *IMMUNOREGULATION , *PROGRAMMED death-ligand 1 , *PROGRAMMED cell death 1 receptors , *PROTEIN metabolism , *INTERLEUKINS , *CYTOKINES , *INTERLEUKIN-2 , *IMMUNOLOGY technique , *INTERFERONS , *ANTIGENS - Abstract
Objective: To analyze the role of PD-1/PD-L1 signaling pathway in regulating T cell activation and secretion of proinflammatory factors in atrial fibrillation.Methods: Forty-five patients with atrial fibrillation admitted to the cardiology department of our hospital from July 2019 to March 2021 were selected to be included in the atrial fibrillation group, and another 45 healthy volunteers were selected as the control group to compare the changes of T cell CD69 and human leukocyte antigen-DR (HLA-DR) expression in the peripheral blood of the two study groups; compare the changes of programmed death factor-1 on CD4+ and CD8+ lymphocytes in the peripheral blood of the two groups (PD-1) expression changes and PD-L1 and PD-L2 expression changes on peripheral blood myeloid dendritic cells (mDCs) cells; compare the changes of interleukin-2, interleukin-6, interleukin-10, and interleukin-17A (IL-2, IL-6, IL-10, and IL-17), tumor necrosis factor (TNF), and interferon gamma (IFN-γ) concentrations on peripheral blood inflammatory factors in the two groups; and isolate the two groups of peripheral blood mDCs cells; α interferon upregulated PD-L1 expression in the cells and analyzed the effect of PD-L1 expression on the ability of mDCs to stimulate T cells to secrete cytokines.Results: The positive expression rates of CD69 and HLA-DR on peripheral blood CD3+ T lymphocytes were significantly higher in patients in the atrial fibrillation group than in the control group, and the differences were statistically significant (P < 0.01). The positive expression rate of PD-1 on CD4+ lymphocytes was significantly lower in patients in the atrial fibrillation group than in the control group (P < 0.01). There was no statistically significant difference between the two groups in terms of PD-1 positive expression rate on CD8+ lymphocytes (P > 0.05). The positive expression rate of PD-L1 on mDCs cells was significantly lower in patients in the atrial fibrillation group than in the control group (P < 0.01), and there was no statistically significant difference between the two groups in the positive expression rate of PD-L2 on mDCs cells, PD-L1, and PD-L2 on CD4+ and CD8+ T cells (P > 0.05). The concentrations of IL-2, IL-6, IL-10, and IFN-γ in peripheral blood were significantly higher in patients in the atrial fibrillation group than in the control group (P < 0.05), and there was no statistically significant difference in the comparison of IL-17A and TNF concentrations in peripheral blood between the two groups (P > 0.05). In the atrial fibrillation group, the ability of mDCs to stimulate T cells to secrete IL-2 and IFN-γ was significantly higher, and the ability to secrete IL-10 was significantly lower compared with the control group (P < 0.05). After α interferon upregulated PD-L1 expression in cells, the ability of mDCs to stimulate T cells to secrete IL-2, IL-10, and IFN-γ cytokines was reversed in patients in the atrial fibrillation group, and the differences compared with the control group were not statistically significant (P > 0.05).Conclusion: PD-1/PD-L1 signaling pathway may play an immunomodulatory role in the pathogenesis of atrial fibrillation by promoting increased secretion of inflammatory factors through regulating T cell activation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
137. Regulation of Il-2 on the expression of granzyme B- and perforin-like genes and its functional implication in grass carp peripheral blood neutrophils.
- Author
-
Lv, Mengyuan, Qiu, Xingyang, Wang, Jiankang, Wang, Yawen, Liu, Qingqing, Zhou, Hong, Zhang, Anying, and Wang, Xinyan
- Subjects
- *
CYTOTOXIC T cells , *CTENOPHARYNGODON idella , *GRANZYMES , *NEUTROPHILS , *NATURAL immunity , *PERFORINS , *CELL death - Abstract
Granzyme (Gzm) B and perforin, both as cytotoxic proteins, can collaborate to induce the death of target cells as well as the microbes. They were originally discovered in cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells and confer the cytotoxic activities of these cells. In the present study, the coding sequences of a granzyme b-like (gc gzmbl) and a perforin-like (gc prfl) genes were cloned from grass carp (Ctenopharyngodon idellus) and their specific antibodies were subsequently prepared and validated. The mRNA and protein expression of these two cytotoxic proteins in grass carp peripheral blood neutrophils was demonstrated by quantitative PCR (qPCR) and immunofluorescence staining, respectively. In the same cell model, expression of gcGzmbl and gcPrfl was stimulated by grass carp interleukin (Il)-2 in a dose- and time-dependent manners and Erk, NF-κB and Stat5 pathways were found to be involved in the regulation of Il-2 on the genes' expression. Additionally, glycolysis was proved to play a role in the stimulation of Il-2 on gcGzmbl and gcPrfl expression in peripheral blood neutrophils. As combating the invading microorganisms is one of the main functions of neutrophils, the roles of gcGzmbl and gcPrfl in the anti-bacterial activities of grass carp peripheral blood neutrophils were explored. Results showed that immunoneutralization of gcGzmbl or gcPrfl significantly attenuated the antimicrobial abilities of the neutrophils enhanced by Il-2. These findings shed a light on the expression, regulation and functions of granzyme B- and perforin-like proteins in fish peripheral blood neutrophils and enrich the understanding of Il-2 function in fish innate immunity. • Granzyme B- and perforin-like molecules are expressed in grass carp neutrophils. • gcIl-2 stimulates Granzyme B- and perforin-like genes expression in the neutrophils. • Erk, NF-κB and Stat5 pathways are involved in the stimulatory effects of Il-2. • Glycolysis is required by the cells to express granzyme B- and perforin-like proteins. • Antibodies for these two proteins attenuate the neutrophils' antimicrobial activities. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
138. The Association between IL2 Genotypes and Risk and Severity of Chronic Periodontitis in a Chinese Han Population: A Case-control Study.
- Author
-
Wang, Xuming and Feng, Chao
- Abstract
Chronic periodontitis (CP) is a kind of multifactorial common oral diseases. Multiple immune molecules including interleukin-2 (IL-2) are involved in the occurrence and development of CP. To investigate the association between the IL2 rs2069762 polymorphism and the risk of CP in Chinese individuals, we recruited 375 CP patients and 443 controls in this case-control study. The PCR-RFLP method was used for genotyping. Data revealed that the GG genotype was related with a decreased risk of CP (GG vs TT: OR, 0.58, 95%CI, 0.37–0.92, P-value = 0.020; GG vs TG+TT: OR, 0.61, 95%CI, 0.39–0.94, P-value = 0.027). Besides, G allele was shown to decrease the risk of CP. In addition, the IL2 rs2069762 polymorphism was related with the severity of CP. To sum up, the IL2 rs2069762 polymorphism is related with a decreased risk and severity of CP in Chinese individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
139. ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.
- Author
-
Saba, Corey, Eggleston, Randall, Parks, Andrew, Peroni, John, Sjoberg, Eric, Rice, Shelbe, Tyma, Jesse, Williams, Jarred, Grosenbaugh, Deborah, and Leard, A. Timothy
- Subjects
- *
SARCOIDOSIS , *INTERLEUKIN-2 , *HORSE breeding , *HORSES , *PILOT projects , *PROGRESSION-free survival , *CANCER invasiveness - Abstract
Background: Sarcoid tumors are common in horses and may negatively impact the performance and value of the horse. No known treatment is reliably successful. Hypotheses/Objectives: To determine tolerability, overall response rate, time to response, and progression‐free survival of horses with biopsy‐confirmed or suspected sarcoids treated with ALVAC‐fIL2. Animals: Client‐owned horses with measurable, presumed‐ or biopsy‐confirmed sarcoid tumors. Methods: Prospective pilot study. One milliliter of ALVAC‐fIL2 was injected into 4 to 5 areas of the sarcoid(s) in each horse (week 0); this treatment was repeated in weeks 1, 3, and 7. Sarcoids were measured at each visit, and response to treatment was determined according to the Response Evaluation Criteria in Solid Tumors for dogs (v1.0). After the final treatment, horses were reassessed and sarcoids remeasured every 3 months until tumor progression or for a minimum of 1 year if progression was not documented. Results: Fourteen horses were included. Tumor size decreased in 86% of the horses, and the median time to first response was 89 days (range, 34‐406 days). Median time to best response was 211 days (range, 56‐406 days), but 3 of the sarcoids still were decreasing in size at the time of final evaluation. The median progression‐free interval was not reached. Adverse events were minimal and included transient focal inflammation in 2 horses. Conclusions and Clinical Importance: Intratumoral injection of ALVAC‐fIL2 has promise as a well‐tolerated and effective, tissue‐sparing treatment for horses with sarcoid tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
140. Sex Differences Distinctly Impact High-Fat Diet-Induced Immune Dysfunction in Wistar Rats.
- Author
-
Braga Tibaes, Jenneffer Rayane, Azarcoya-Barrera, Jessy, Wollin, Bethany, Veida-Silva, Hellen, Makarowski, Alexander, Vine, Donna, Tsai, Sue, Jacobs, René, Richard, Caroline, and Braga Tibaes, Jenneffer Rayane
- Subjects
- *
HUMAN reproduction , *CYTOKINES , *OBESITY , *INTERLEUKIN-2 , *ANIMAL experimentation , *DIET , *RATS , *CARBOHYDRATES , *RESEARCH funding , *ANIMALS - Abstract
Background: Immune function is altered during obesity. Moreover, males and females across different species demonstrate distinct susceptibility to several diseases. However, less is known regarding the interplay between high-fat diet (HFD) and sex in the context of immune function.Objectives: The objective was to determine sex differences on immune function in response to an HFD compared with a control low-fat diet (LFD) in Wistar rats.Methods: At 5 wk of age, male and female Wistar rats were randomly assigned to 1 of 2 diets for 9 wk: ad libitum control LFD (20 kcal% fat, 53 kcal% carbohydrate, and 27 kcal% protein) or HFD (50 kcal% fat, 23 kcal% carbohydrate, and 27 kcal% protein). At 13 wk of age, rats were killed and splenocytes were isolated. Immune cell subsets were determined by flow cytometry. Immune cell function was determined by measuring the ex vivo cytokine production following stimulation with mitogens. Two-factor ANOVA was used to assess the main effect of sex, diet, and their interaction.Results: Males gained more weight than females (410 ± 46 vs. 219 ± 45 g), independently of diet (P-sex < 0.01). The HFD led to a lower production of IL-2 while increasing the production of IL-10 (both P-diet ≤ 0.05), independently of sex. HFD-fed females had increased production of cytokines (IL-2 and IL-6) after stimulation with phorbol 12-myristate 13-acetate plus ionomycin (PMA+I), as well as a higher T-helper (Th) 1:Th2 balance compared with HFD-fed males (all P < 0.05). Males fed the HFD had significantly lower production of IL-2 upon stimulation compared with all other groups.Conclusions: Female Wistar rats developed a milder obesity phenotype and maintained enhanced cytokine production compared with males fed the HFD. Sex differences modulate immune function in the context of high-fat feeding and it should be considered in research design to establish personalized health-related recommendations. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
141. Cytokine Storm Due to Intralesional Intelukin-2 Therapy for Cutaneous In-Transit Melanoma.
- Author
-
Isaq, Nasro A., Brewer, Jerry, Markovic, Svetomir N., Montane, Heather, and Demer, Addison M.
- Subjects
- *
CYTOKINE release syndrome , *PATIENT experience , *MELANOMA , *CRITICAL care medicine , *INTERLEUKIN-2 - Abstract
This article discusses the case of a 65-year-old woman with metastatic melanoma who received intralesional interleukin-2 (IL-2) injections for in-transit disease. Intralesional IL-2 is a localized treatment option for melanoma that typically has mild side effects. However, in this case, the patient experienced a cytokine storm, a potentially life-threatening complication characterized by systemic cytokine release. The patient was hospitalized and received intensive care management. This case highlights the importance of early recognition and management of cytokine storms associated with intralesional IL-2 therapy. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
142. Associations between Serum Interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis.
- Author
-
Chang, Yuanmin, Bai, Mengru, and You, Qinghai
- Subjects
- *
BLOOD serum analysis , *INTERLEUKINS , *ONLINE information services , *NONPARAMETRIC statistics , *COVID-19 , *META-analysis , *MEDICAL information storage & retrieval systems , *CONFIDENCE intervals , *SYSTEMATIC reviews , *INTERLEUKIN-2 , *CRITICALLY ill , *PATIENTS , *SEVERITY of illness index , *DESCRIPTIVE statistics , *MEDLINE - Abstract
Background. To investigate the association between interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19). Materials and Methods. We systematically searched records investigating the role of interleukins (IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10) in COVID-19 patients in Web of Science, Pubmed, and Embase through December 2020. Data were extracted and pooled, and the weighted mean difference (WMD) and its 95% confidence interval (CI) were calculated. The funnel plot and the nonparametric trim and fill method were used to visualize and adjust the publication bias. Results. In total, 61 studies enrolled 14,136 subjects (14,041 patients and 95 healthy subjects) were enrolled in this meta-analysis. Our results showed that serum IL-2, IL-4, IL-6, and IL-10 levels were elevated in COVID-19 patients compared to healthy controls, and IL-6, IL-8, and IL-10 levels were increased in severe COVID-19 cases compared to nonsevere patients. Additionally, the levels of IL-1β, IL-6, and IL-8 were elevated in nonsurvivor patients compared to survivors. For patients in the intensive care unit (ICU), IL-6 and IL-8 levels were increased than that in non-ICU patients. Conclusions. Elevated levels of IL-6, IL-8, and IL-10 were associated with the disease severity of COVID-19, and elevated levels of IL-1β, IL-6, and IL-8 were related to the prognosis of COVID-19 patients, which could be used to evaluate COVID-19 patients' disease severity and prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
143. Addressing the role of PKD3 in the T cell compartment with knockout mice.
- Author
-
Koutník, Jiří, Neururer, Verena, Gruber, Thomas, Peer, Sebastian, Hermann-Kleiter, Natascha, Olson, William J., Labi, Verena, Leitges, Michael, Baier, Gottfried, and Siegmund, Kerstin
- Subjects
- *
KNOCKOUT mice , *T cell differentiation , *T cell receptors , *PROTEIN kinases , *INTERLEUKIN-2 , *T cells , *T helper cells - Abstract
Background: The Protein kinase D3 (PKD3) has been implicated in signal transduction downstream of the T cell receptor (TCR). However, its role for the activation of primary T lymphocytes has not been elucidated so far. Methods: Expression of PKD isoforms in primary murine T cells was determined by RT-PCR and SDS-Page. A germline PKD3-knockout mouse line was analyzed for its immune response to OVA/alum intraperitoneal immunization. Phenotyping of the T cell compartment ex vivo as well as upon stimulation in vitro was performed by flow cytometry. Additionally, cytokine expression was assessed by flow cytometry, RT-PCR and Luminex technology. Results: PKD expression in T cells is modulated by TCR stimulation, leading to a rapid down-regulation on mRNA and on protein level. PKD3-deficient mice respond to immunization with enhanced T follicular helper cell generation. Furthermore, peripheral PKD3-deficient CD4+ T cells express more interleukin-2 than wild type CD4+ T cells upon TCR stimulation ex vivo. However, purified naïve CD4+ T cells do not differ in their phenotype upon differentiation in vitro from wild type T cells. Moreover, we observed a shift towards an effector/memory phenotype of splenic T cells at steady state, which might explain the contradictory results obtained with pan-T cells ex vivo and naïve-sorted T cells. Conclusion: While PKD3-deficiency in vivo in mice leads to a skewing of the T cell compartment towards a more activated phenotype, this kinase seems to be dispensable for naïve CD4+ T cell differentiation in vitro. C25hFQnb9jgLSuxBMgU4K9 Video Abstract [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
144. Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence.
- Author
-
Johnson, Michael J, Liu, Cuining, Ghosh, Debashis, Lang, Nancy, Levin, Myron J, and Weinberg, Adriana
- Subjects
- *
RESEARCH , *INTERLEUKIN-2 , *RESEARCH methodology , *EVALUATION research , *INTERFERONS , *COMPARATIVE studies , *RANDOMIZED controlled trials , *HERPES zoster vaccines , *HERPES zoster , *RESEARCH funding , *CELLULAR immunity , *HERPESVIRUSES - Abstract
We compared glycoprotein E (gE)- and varicella zoster virus (VZV)-specific Th1 immunity in 160 adults, aged 50-85 years, randomized to receive live or recombinant zoster vaccine (RZV). gE-specific responses measured by interferon-γ (IFN-γ) and interleukin 2 (IL-2) dual-color Fluorospot were significantly higher at all time points postimmunization in RZV recipients. VZV-specific IL-2+ memory, but not IFN-γ+ or IFN-γ+IL-2+ effector responses, were higher in RZV recipients at ≥3 months postimmunization. Only RZV recipients maintained higher postvaccination gE-specific IL-2+ and IFN-γ+ and VZV-specific IL-2+ responses for 5 years. The 5-year persistence of VZV-specific memory and gE-specific Th1 immunity may underlie superior RZV efficacy. Clinical Trials Registration NCT02114333. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
145. IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression.
- Author
-
Chen, Hao, Tang, Chao, Tan, Chun, Wu, Fei, Li, Zhenhan, Ji, Wenyan, Lu, Linming, Xu, Chongjun, Shen, Zhengchao, and Huang, Yanqiang
- Subjects
- *
HEPATOCELLULAR carcinoma , *EXOSOMES , *MICRORNA , *INTERLEUKIN-2 , *CELL proliferation - Abstract
Background. Interleukin-2 (IL-2) is proved to play an irreplaceable role in antitumor regulation in numerous experimental and clinical trials. Tumor-associated macrophages (TAMs) are able to release exosomes to promote the development and progression of hepatocellular carcinoma (HCC) as essential component of microenvironment. In this study, our intention is to explore the effects of the exosomes from TAMs with IL-2 treatment on HCC development. TAMs were collected and cultured from HCC tissues. The exosomes from the TAMs treated with IL-2 (ExoIL2-TAM) or not (ExoTAM) were identified and used to treat HCC cells in vivo and in vitro. The proliferation, apoptosis, and metastasis of HCC cells were measured. The changes of miRNAs in exosomes were explored to clarify the possible mechanisms. Both decrease of cell proliferation and metastasis and increase of apoptosis were observed with ExoIL2-TAM treatment compared with ExoTAMin vivo and in vitro. miR-375 was obviously augmented in ExoIL2-TAM and HCC cells treated with ExoIL2-TAM. Taken together, IL-2 may modulate exosomal miRNAs from TAMs to ameliorate hepatocellular carcinoma development. This study provides a new perspective to explain the mechanism by which IL-2 inhibits hepatocellular carcinoma and implies the potential clinical value of exosomal miRNAs released by TAMs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
146. In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls.
- Author
-
Rachayon, Muanpetch, Jirakran, Ketsupar, Sodsai, Pimpayao, Klinchanhom, Siriwan, Sughondhabirom, Atapol, Plaimas, Kitiporn, Suratanee, Apichat, and Maes, Michael
- Subjects
- *
INTERLEUKIN-2 , *CANNABIS (Genus) , *CANNABIDIOL , *IMMUNOSUPPRESSION , *MENTAL depression - Abstract
Major depressive disorder and major depressive episodes (MDD/MDE) are characterized by the activation of the immune–inflammatory response system (IRS) and the compensatory immune–regulatory system (CIRS). Cannabidiol (CBD) is a phytocannabinoid isolated from the cannabis plant, which is reported to have antidepressant-like and anti-inflammatory effects. The aim of the present study is to examine the effects of CBD on IRS, CIRS, M1, T helper (Th)-1, Th-2, Th-17, T regulatory (Treg) profiles, and growth factors in depression and healthy controls. Culture supernatant of stimulated (5 μg/mL of PHA and 25 μg/mL of LPS) whole blood of 30 depressed patients and 20 controls was assayed for cytokines using the LUMINEX assay. The effects of three CBD concentrations (0.1 µg/mL, 1 µg/mL, and 10 µg/mL) were examined. Depression was characterized by significantly increased PHA + LPS-stimulated Th-1, Th-2, Th-17, Treg, IRS, CIRS, and neurotoxicity profiles. CBD 0.1 µg/mL did not have any immune effects. CBD 1.0 µg/mL decreased CIRS activities but increased growth factor production, while CBD 10.0 µg/mL suppressed Th-1, Th-17, IRS, CIRS, and a neurotoxicity profile and enhanced T cell growth and growth factor production. CBD 1.0 to 10.0 µg/mL dose-dependently decreased sIL-1RA, IL-8, IL-9, IL-10, IL-13, CCL11, G-CSF, IFN-γ, CCL2, CCL4, and CCL5, and increased IL-1β, IL-4, IL-15, IL-17, GM-CSF, TNF-α, FGF, and VEGF. In summary, in this experiment, there was no beneficial effect of CBD on the activated immune profile of depression and higher CBD concentrations can worsen inflammatory processes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
147. High-fat diet induced hippocampal CREB dysfunction, cognitive impairment and depression-like behaviors via downregulation of interleukin-2 in the mice.
- Author
-
Chen, Zheng, Sui, Guanghong, Wang, Lu, Yang, Caixia, and Wang, Feng
- Subjects
- *
HIGH-fat diet , *MONONUCLEAR leukocytes , *INTERLEUKIN-2 , *COGNITION disorders , *HIPPOCAMPUS (Brain) - Abstract
background: Inhibition of hippocampal CREB signaling contributed to obesity-induced cognitive impairment. But, the potential mechanism by which obesity inhibits hippocampal CREB signaling is not clear. The aim of this study was to explore whether interleukin-2 played a intermediary role in this pathogenic effect in a high-fat diet model. Methods: C57BL/6J interleukin-2+/+ wild-type and interleukin-2−/− knockout mice were fed a standard diet or high-fat diet for 12 weeks. After that, cognitive function was assessed by Morris water maze and Y maze. Depression-like behaviors were determined using sucrose preference test and tail suspension test. Expression of p-CREB and interleukin-2 in peripheral blood mononuclear cells and hippocampus was measured using western blotting and qRT-PCR. Results: In the interleukin-2+/+ wild-type mice, a high-fat diet inhibited the expression of interleukin-2 and p-CREB both in the peripheral blood mononuclear cells and hippocampus. The high-fat diet also caused cognitive impairment and depression-like behaviors in these mice. In the interleukin-2−/− knockout mice, there was no significant depression of interleukin-2. A high-fat diet can only aggravate the p-CREB signaling dysfunction in the peripheral blood mononuclear cells, but not in the hippocampus. Meanwhile, the high-fat diet can not cause the cognitive impairment and depression-like behaviors in these mice. Conclusions: A high-fat diet induced hippocampal CREB dysfunction, cognitive impairment and depression-like behaviors partly through downregulation of interleukin-2 in the mice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
148. Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients.
- Author
-
Gatselis, Nikolaos K., Lygoura, Vasiliki, Lyberopoulou, Aggeliki, Giannoulis, George, Samakidou, Anna, Vaiou, Antonia, Vatidis, George, Antoniou, Katerina, Stefos, Aggelos, Georgiadou, Sarah, Sagris, Dimitrios, Sveroni, Dafni, Stergioula, Despoina, Gabeta, Stella, Ntaios, George, and Dalekos, George N.
- Subjects
- *
RESPIRATORY insufficiency , *COVID-19 , *INTUBATION , *INTERLEUKIN-2 , *MORTALITY , *TREATMENT effectiveness - Abstract
Risk stratification of coronavirus disease-19 (COVID-19) patients by simple markers is critical to guide treatment. We studied the predictive value of soluble interleukin-2 receptor (sIL-2R) for the early identification of patients at risk of developing severe clinical outcomes. sIL-2R levels were measured in 197 patients (60.9% males; median age 61 years; moderate disease, n = 65; severe, n = 132, intubated and/or died, n = 42). All patients received combined immunotherapies (anakinra ± corticosteroids ± intravenous immunoglobulin ± tocilizumab) according to our local treatment algorithm. The endpoint was the composite event of intubation due to severe respiratory failure (SRF) or mortality. Median (interquartile range) sIL-2R levels were significantly higher in patients with severe disease, compared with those with moderate disease (6 (6.2) vs. 5.2 (3.4) ng/mL, p = 0.017). sIL-2R was the strongest laboratory predictive factor for intubation/death (hazard ratio 1.749, 95%CI 1.041–2.939, p = 0.035) after adjustment for other known risk factors. Youden's index revealed optimal sIL-2R cut-off for predicting intubation/death at 9 ng/mL (sensitivity: 67%; specificity: 86%; positive and negative predictive value: 57% and 91%, respectively). Delta sIL-2R between the day of event or discharge minus admission date was higher in patients that intubated/died than in those who did not experience an event (2.91 (10.42) vs. 0.44 (2.88) ng/mL; p = 0.08)). sIL-2R on admission and its dynamic changes during follow-up may reflect disease severity and predict the development of SRF and mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
149. Microwave ablation of non-small cell lung cancer tumors changes plasma levels of cytokines IL-2 and IFN-γ.
- Author
-
Xu, Hui, Tan, Xiaojing, Kong, Yongmei, Huang, Yahan, Wei, Zhigang, and Ye, Xin
- Subjects
- *
TREATMENT of lung tumors , *LUNG cancer , *CYTOKINES , *INTERLEUKIN-2 , *MICROWAVES , *CELL physiology , *RETROSPECTIVE studies , *INTERFERONS , *TUMOR necrosis factors - Abstract
Background: Combined therapy with immune checkpoint inhibitors (ICIs) and microwave ablation (MWA) is known to improve outcome in non-small cell lung cancer (NSCLC). However, the mechanism underlying the synergistic effect of these two treatments is unknown. Tumor immune microenvironment is known to affect the efficacy of ICI. Therefore, in the present study, we evaluated changes in the levels of peripheral cytokines at 48 h and 1-month post-ablation in patients with NSCLC.Materials and Methods: A total of 44 patients with primary NSCLC were retrospectively enrolled. All patients underwent MWA of the primary tumors. Plasma samples were collected pre- and post-ablation to examine the levels of various cytokines, including interleukin (IL)-2, IL-4, IL-6, IL-10, IL-12, IL-17, tumor necrosis factor (TNF)-α, and interferon-gamma (IFN-γ).Results: Although the levels of the majority of cytokines remained within normal range, levels of IL-2 and IFN-γ were significantly decreased at 48 h post-ablation and increased at 1-month post-ablation. In the subgroup analyses, changes in IL-2 and IFN-γ levels were commonly identified. Moreover, the Eastern Cooperative Oncology Group status, sex, pathology type, tumor site, and tumor size were associated with cytokines' levels pre-ablation or post-ablation.Conclusion: MWA of NSCLC tumors influenced the plasma levels of cytokines IL-2 and IFN-γ. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
150. Revealing Functional Significance of Interleukin‐2 Glycoproteoforms Enabled by Expressed Serine Ligation.
- Author
-
Zhao, Jie, Liu, Jiazhi, Liu, Xinnan, Cao, Qi, Zhao, Hongbo, Liu, Lizhen, Ye, Farong, Wang, Can, Shao, Hong, Xue, Dongxiang, Tao, Houchao, Li, Bin, Yu, Biao, and Wang, Ping
- Subjects
- *
INTERLEUKIN-2 , *SERINE , *T cell differentiation , *T cells , *GLYCANS , *CLINICAL medicine - Abstract
Comprehensive Summary: Naturally occurring interleukin‐2 (IL‐2) is a pleiotropic glycoprotein that regulates immune responses by controlling the differentiation and homeostasis of T cells. Non‐glycosylated IL‐2 has been used in clinical settings for three decades. However, the function of the O‐glycan of native IL‐2 remains elusive. Herein, to stress this issue, we report a highly efficient semi‐synthesis of homogeneous glycosylated IL‐2 with various glycoproteoforms on a multi‐milligram scale. The glycopeptide fragment was prepared by chemical synthesis and then merged with recombinant fragment via a serine ligation to generate the desired glycoprotein in a single operation. Biological evaluation of the homogenous glycoprotein library reveals that the activity of IL‐2 in activating individual T cell subset is glycan dependent, thus highlighting the possibility of further improving current clinical medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.